TrialBlood2008
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.
Brian G Till et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
393 papers cite itlatest 60 shown
this paperpooled itcites it